These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14734177)

  • 41. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 42. Mutational analysis of the OprM outer membrane component of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
    Li XZ; Poole K
    J Bacteriol; 2001 Jan; 183(1):12-27. PubMed ID: 11114896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
    Buyck JM; Guénard S; Plésiat P; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Mar; 67(3):771-5. PubMed ID: 22218683
    [No Abstract]   [Full Text] [Related]  

  • 44. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Organic solvent-tolerant mutants of Pseudomonas aeruginosa display multiple antibiotic resistance.
    Li XZ; Poole K
    Can J Microbiol; 1999 Jan; 45(1):18-22. PubMed ID: 10349716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran.
    Goli HR; Nahaei MR; Rezaee MA; Hasani A; Samadi Kafil H; Aghazadeh M; Sheikhalizadeh V
    Infect Genet Evol; 2016 Nov; 45():75-82. PubMed ID: 27562333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal structure of the MexR repressor of the mexRAB-oprM multidrug efflux operon of Pseudomonas aeruginosa.
    Lim D; Poole K; Strynadka NC
    J Biol Chem; 2002 Aug; 277(32):29253-9. PubMed ID: 12034710
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular typing and resistance mechanisms of carbapenem resistant Pseudomonas aeruginosa isolated from a Chinese surgical intensive care unit.
    Yi M; Wang P; Liu Y
    Chin Med J (Engl); 2014; 127(6):1071-6. PubMed ID: 24622437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Two efflux systems expressed simultaneously in clinical Pseudomonas aeruginosa].
    Hocquet D; Llanes C; Patry I; El Garch F; Plésiat P
    Pathol Biol (Paris); 2004 Oct; 52(8):455-61. PubMed ID: 15465264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to beta-lactams due to reduced expression of the ampC beta-lactamase.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Nishino T
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1284-6. PubMed ID: 11257048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
    Boutoille D; Jacqueline C; Le Mabecque V; Potel G; Caillon J
    Int J Antimicrob Agents; 2009 May; 33(5):417-20. PubMed ID: 19157801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance.
    Andrésen C; Jalal S; Aili D; Wang Y; Islam S; Jarl A; Liedberg B; Wretlind B; Mårtensson LG; Sunnerhagen M
    Protein Sci; 2010 Apr; 19(4):680-92. PubMed ID: 20095047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of resistance in clinical isolates of Pseudomonas aeruginosa less susceptible to cefepime than to ceftazidime.
    Campo Esquisabel AB; Rodríguez MC; Campo-Sosa AO; Rodríguez C; Martínez-Martínez L
    Clin Microbiol Infect; 2011 Dec; 17(12):1817-22. PubMed ID: 21599797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
    Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
    FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of MexAB-OprM efflux pump system and susceptibility to antibiotics of different Pseudomonas aeruginosa clones isolated from patients hospitalized in two intensive care units at University Hospital in Bialystok (northeastern Poland) between January 2002 and December 2009.
    Sacha P; Wieczorek P; Ojdana D; Hauschild T; Milewski R; Czaban S; Poniatowski B; Tryniszewska E
    APMIS; 2014 Oct; 122(10):931-40. PubMed ID: 24628702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.